---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-06-03T09:54:55.390353'
end_time: '2026-06-03T10:02:13.975321'
duration_seconds: 438.59
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: AGR3
  gene_symbol: AGR3
  uniprot_accession: Q8TD06
  protein_description: 'RecName: Full=Anterior gradient protein 3; Short=AG-3; Short=AG3;
    Short=hAG-3; AltName: Full=Anterior gradient 3 homolog {ECO:0000312|HGNC:HGNC:24167};
    AltName: Full=Breast cancer membrane protein 11 {ECO:0000312|HGNC:HGNC:24167};
    AltName: Full=Protein disulfide isomerase family A, member 18 {ECO:0000312|HGNC:HGNC:24167};
    Flags: Precursor;'
  gene_info: Name=AGR3; Synonyms=BCMP11, PDIA18; ORFNames=UNQ642/PRO1272;
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the AGR family. .
  protein_domains: AGR/TXD. (IPR051099); Thioredoxin-like_sf. (IPR036249); Thioredoxin_7
    (PF13899)
provider_config:
  timeout: null
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
    max_embedded_images: 8
citation_count: 16
artifact_count: 1
artifact_sources:
  edison_answer_artifacts: 1
artifacts:
- filename: artifact-00.md
  path: AGR3-deep-research-falcon_artifacts/artifact-00.md
  media_type: text/markdown
  source: edison_answer_artifacts
  data_storage_id: null
  description: Edison artifact artifact-00
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q8TD06
- **Protein Description:** RecName: Full=Anterior gradient protein 3; Short=AG-3; Short=AG3; Short=hAG-3; AltName: Full=Anterior gradient 3 homolog {ECO:0000312|HGNC:HGNC:24167}; AltName: Full=Breast cancer membrane protein 11 {ECO:0000312|HGNC:HGNC:24167}; AltName: Full=Protein disulfide isomerase family A, member 18 {ECO:0000312|HGNC:HGNC:24167}; Flags: Precursor;
- **Gene Information:** Name=AGR3; Synonyms=BCMP11, PDIA18; ORFNames=UNQ642/PRO1272;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the AGR family. .
- **Key Domains:** AGR/TXD. (IPR051099); Thioredoxin-like_sf. (IPR036249); Thioredoxin_7 (PF13899)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "AGR3" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'AGR3' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **AGR3** (gene ID: AGR3, UniProt: Q8TD06) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q8TD06
- **Protein Description:** RecName: Full=Anterior gradient protein 3; Short=AG-3; Short=AG3; Short=hAG-3; AltName: Full=Anterior gradient 3 homolog {ECO:0000312|HGNC:HGNC:24167}; AltName: Full=Breast cancer membrane protein 11 {ECO:0000312|HGNC:HGNC:24167}; AltName: Full=Protein disulfide isomerase family A, member 18 {ECO:0000312|HGNC:HGNC:24167}; Flags: Precursor;
- **Gene Information:** Name=AGR3; Synonyms=BCMP11, PDIA18; ORFNames=UNQ642/PRO1272;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the AGR family. .
- **Key Domains:** AGR/TXD. (IPR051099); Thioredoxin-like_sf. (IPR036249); Thioredoxin_7 (PF13899)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "AGR3" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'AGR3' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **AGR3** (gene ID: AGR3, UniProt: Q8TD06) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Research report: Human **AGR3 / PDIA18** (UniProt **Q8TD06**) functional annotation

### 0) Target verification (critical identity check)
AGR3 in this report refers specifically to the **human** protein **Anterior gradient protein 3**, also annotated as **PDIA18** (protein disulfide isomerase family A member 18), corresponding to UniProt accession **Q8TD06**. It is a **small (~166 aa) single-domain thioredoxin/PDI-family protein** with a **noncanonical CXXS-like active-site region** and a **C‑terminal ER retention signal** (QSEL), consistent across structural, airway-epithelium, and review literature describing AGR3 (bonser2015theendoplasmicreticulum pages 1-5, boisteau2022anteriorgradientproteins pages 6-10, nguyen2018crystalstructureof pages 1-2).

### 1) Key concepts and definitions (current understanding)

#### 1.1 AGR family and PDI/thioredoxin context
AGR3 is part of the **anterior gradient (AGR) family** (AGR1/AGR2/AGR3), a subset of **protein disulfide isomerase (PDI)**-related proteins typically associated with the **secretory pathway** and the **endoplasmic reticulum (ER)**. Reviews position AGR proteins as PDI-like factors involved in **secretory and transmembrane protein biogenesis in the ER** (boisteau2022anteriorgradientproteins pages 1-6, boisteau2022anteriorgradientproteins pages 6-10).

A key concept for AGR3 is that, unlike canonical PDIs that catalyze thiol–disulfide exchange via a **CXXC** motif, AGR3 contains a **noncanonical motif** that lacks the second catalytic cysteine, implying **atypical or reduced classical thiol–disulfide exchange capability** (nguyen2018crystalstructureof pages 1-2, nguyen2018crystalstructureof pages 5-6).

#### 1.2 What “catalytic activity” likely means for AGR3
The AGR3 crystal structure literature explicitly emphasizes divergence from the canonical catalytic PDI motif and interprets this as evidence that AGR3 is **unlikely to function as a typical thiol–disulfide exchange enzyme** in oxidative protein folding (nguyen2018crystalstructureof pages 1-2). Thus, AGR3 is best conceptualized as a **PDI-family/thioredoxin-fold protein whose primary biological roles may include selective protein–protein interactions, chaperone-like behavior, or specialized quality-control functions**, rather than broad-spectrum disulfide isomerization.

### 2) Molecular features: domains, motifs, and structural mechanism

#### 2.1 Domain architecture and targeting signals
AGR3 is described as a **single-domain thioredoxin/PDI-like protein** that is routed into the secretory pathway by an **N‑terminal signal peptide** and contains a **nonstandard ER-retention sequence QSEL** (nguyen2018crystalstructureof pages 1-2, boisteau2022anteriorgradientproteins pages 6-10).

#### 2.2 Active-site motif and catalytic implications (structure-informed)
Crystal structure work reports that AGR3 **lacks the canonical WCXXC/CXXC active-site motif** and instead contains **DCYQS** at the equivalent position (nguyen2018crystalstructureof pages 1-2). Structural analysis places this motif in helix 2 and identifies **Cys71** as **solvent-exposed** and **observed in a reduced (not oxidized) state** in the crystal (nguyen2018crystalstructureof pages 3-5).

Mechanistically, the missing second cysteine (relative to CXXC PDIs) and the presence of an adjacent acidic residue predicted to modulate cysteine pKa support the interpretation that AGR3 has **reduced/altered thiolate reactivity** and therefore may not efficiently catalyze classical disulfide exchange reactions characteristic of canonical PDIs (nguyen2018crystalstructureof pages 5-6, nguyen2018crystalstructureof pages 1-2). Nonetheless, the exposed cysteine and nearby structural elements (e.g., a cis-proline near the motif) are consistent with a role in **substrate binding or specialized redox interactions** (nguyen2018crystalstructureof pages 3-5).

#### 2.3 Oligomerization state
In the AGR3 crystal asymmetric unit, two molecules associate, but the authors report that biochemical/PISA analyses provide **no evidence for a stable dimer in solution** and that AGR3 lacks a component of the salt bridge found in AGR2 dimers (nguyen2018crystalstructureof pages 3-5). This indicates that **stable dimerization is not strongly supported** for AGR3 under the conditions tested, although transient or context-dependent interactions remain possible.

### 3) Subcellular localization and tissue/cell-type specificity

#### 3.1 ER localization in ciliated airway cells
A core, well-supported feature of AGR3 is its **ER localization in ciliated airway epithelial cells**.

Bonser et al. report ER localization by immunostaining/colocalization: **99.5%** of AGR3 signal colocalized with ER markers (GRP78/GRP94), and AGR3 staining was largely distinct from AGR2 (**97.7%** in regions distinct from AGR2), reinforcing that AGR3 is an ER-resident protein with cell-type specificity in the airway epithelium (bonser2015theendoplasmicreticulum pages 5-10).

#### 3.2 Expression is differentiation-linked and not a canonical ER-stress/UPR target
AGR3 expression increases sharply during airway epithelial differentiation: AGR3 mRNA increased ~**1000‑fold** from day 7 to day 21 in differentiated airway epithelial cultures (bonser2015theendoplasmicreticulum pages 10-13). In contrast to AGR2, AGR3 is **not induced by ER stress**: tunicamycin increased AGR2 mRNA ~**13‑fold** but did not increase AGR3 mRNA (bonser2015theendoplasmicreticulum pages 5-10). Reviews similarly describe AGR3 expression as **independent of ER stress** (boisteau2022anteriorgradientproteins pages 1-6, boisteau2022anteriorgradientproteins pages 6-10).

### 4) Biological function and pathways

#### 4.1 Primary physiological role supported by in vivo genetics: ciliary beat regulation
The strongest mechanistic functional evidence for AGR3 comes from mouse genetics and airway physiology. Agr3 knockout mice (**Agr3−/−**) were viable and had normal ciliary ultrastructure (normal “9+2” arrangement and dynein arms), indicating AGR3 is **not required for ciliogenesis** per se (bonser2015theendoplasmicreticulum pages 10-13).

However, Agr3−/− tracheal cilia exhibited a clear functional defect:
- Baseline ciliary beat frequency (CBF) was reduced by **~20%** vs controls in 1 mM extracellular Ca2+ (bonser2015theendoplasmicreticulum pages 10-13).
- After extracellular ATP stimulation, CBF was **~35% lower** in Agr3−/− tracheas (bonser2015theendoplasmicreticulum pages 10-13).
- Mucociliary particle transport speed was reduced by **35%** in Agr3−/− tracheas, supporting impaired mucociliary clearance (bonser2015theendoplasmicreticulum pages 10-13).

These data define AGR3’s best-supported physiological role as **regulation of ciliary motility and mucociliary clearance**, rather than structural assembly of cilia.

#### 4.2 Calcium signaling link
Bonser et al. provide evidence that the ciliary phenotype is **calcium-dependent**:
- The genotype difference in CBF disappeared in **calcium-free** solution (bonser2015theendoplasmicreticulum pages 10-13).
- Cultured tracheal epithelial cells from Agr3−/− mice had lower intracellular Ca2+ than wild-type (**139.7 ± 98.2 nM** vs **362.1 ± 55.0 nM**, n=6, p<0.001) (bonser2015theendoplasmicreticulum pages 10-13).

Thus, AGR3 appears to influence **intracellular Ca2+ homeostasis/signaling** in ciliated cells in a way that impacts ciliary beat regulation.

### 5) Cancer-related roles and extracellular AGR3 biology

#### 5.1 Cancer associations (overview)
Reviews summarize that AGR3 has been detected beyond the ER context in cancer, including reports of **cell membrane association** and **extracellular AGR3 (eAGR3)**, and that AGR3 expression in breast cancer correlates with estrogen receptor status (boisteau2022anteriorgradientproteins pages 6-10). These observations motivate mechanistic studies of extracellular AGR3.

#### 5.2 Experimental evidence: eAGR3 promotes migration/adhesion and activates Src
A key primary study demonstrated that **breast cancer cells secrete AGR3** and that extracellular AGR3 has functional activity. In ER-positive breast cancer cell lines (MCF‑7, T‑47D), AGR3 was found in conditioned media at **nanomolar concentrations** (obacz2019extracellularagr3regulates pages 2-4). The same study reports **higher serum eAGR3 in breast cancer patients vs healthy controls** (no absolute concentration values were present in the retrieved excerpt) (obacz2019extracellularagr3regulates pages 6-8).

Functionally, recombinant eAGR3 (commonly **5 ng/mL**, tested across ~0.5–50 ng/mL) increased migration in wound-healing assays and increased resistance to detachment in adhesion-related assays (obacz2019extracellularagr3regulates pages 4-6, obacz2019extracellularagr3regulates pages 2-4).

Mechanistically, the study provides both pharmacologic and genetic evidence that eAGR3 acts via **Src kinase signaling**:
- eAGR3 increased **tyrosine phosphorylation** and increased **c‑Src phosphorylation**; Src phosphorylation was blocked by **dasatinib** (obacz2019extracellularagr3regulates pages 4-6).
- Dasatinib (1 µM in migration assays) significantly reduced migration in both control and eAGR3-stimulated cells (obacz2019extracellularagr3regulates pages 4-6).
- A kinase-dead/dominant-negative Src mutant (**K298R**) abolished the migratory response to eAGR3, while wild-type Src did not (obacz2019extracellularagr3regulates pages 4-6).

The authors additionally note that dasatinib did not fully abolish the eAGR3 migration effect, suggesting additional pathways may contribute (obacz2019extracellularagr3regulates pages 6-8).

### 6) Applications and real-world implementations

#### 6.1 Airway biology and mucociliary clearance relevance
Given the magnitude of effects on CBF and mucociliary transport in Agr3−/− models, AGR3 is a plausible **mechanistic node** for disorders where **mucociliary clearance is compromised**, though the provided evidence does not include direct AGR3-targeted therapies (bonser2015theendoplasmicreticulum pages 10-13).

#### 6.2 Potential biomarker concept in breast cancer (early translational signal)
Patient serum elevation of eAGR3 relative to healthy controls suggests a potential **liquid-biopsy biomarker direction**, but the retrieved evidence excerpt does not provide performance metrics (AUC, sensitivity/specificity) or absolute concentration ranges needed for clinical evaluation (obacz2019extracellularagr3regulates pages 6-8).

### 7) Recent developments (2023–2024 prioritization) and evidence limitations
Searches prioritized to 2023–2024 AGR3/PDIA18 did not yield additional AGR3-focused primary literature within the accessible corpus for this run; the most recent authoritative synthesis available here is a 2022 review, while the strongest primary mechanistic studies remain 2015 (airway) and 2019 (extracellular Src signaling) (boisteau2022anteriorgradientproteins pages 6-10, bonser2015theendoplasmicreticulum pages 10-13, obacz2019extracellularagr3regulates pages 4-6). Therefore, this report emphasizes **high-confidence mechanistic findings** from these studies and explicitly avoids extrapolating beyond available evidence.

### 8) Expert synthesis / interpretation (bounded by evidence)
1. **Primary functional annotation (most evidence-supported):** AGR3 is an **ER-resident protein in ciliated airway epithelial cells** that is required for **normal calcium-dependent regulation of ciliary beat frequency** and **effective mucociliary clearance**, without being required for formation of normal ciliary ultrastructure (bonser2015theendoplasmicreticulum pages 10-13, bonser2015theendoplasmicreticulum pages 5-10).
2. **Biochemical role:** Although structurally in the PDI/thioredoxin family, AGR3’s **DCYQS** motif (lacking the second cysteine) supports the view that AGR3 is **not a canonical disulfide isomerase**; it likely mediates **selective protein interactions** or specialized redox behavior rather than generalized thiol–disulfide exchange (nguyen2018crystalstructureof pages 1-2, nguyen2018crystalstructureof pages 5-6, nguyen2018crystalstructureof pages 3-5).
3. **Cancer microenvironment role:** In ER-positive breast cancer cell systems, secreted AGR3 functions as an extracellular signaling effector promoting migration/adhesion, at least partly through **Src activation**, with inhibition by dasatinib and ablation by dominant-negative Src (obacz2019extracellularagr3regulates pages 4-6, obacz2019extracellularagr3regulates pages 2-4).

### 9) Quantitative findings (selected)
- ER colocalization: **99.5%** AGR3 colocalization with GRP78/GRP94; **97.7%** of AGR3 staining distinct from AGR2 (airway ciliated cells) (bonser2015theendoplasmicreticulum pages 5-10).
- Differentiation-associated induction: AGR3 mRNA increased **~1000‑fold** (day 7 → day 21) in airway epithelial differentiation cultures (bonser2015theendoplasmicreticulum pages 10-13).
- ER stress response: tunicamycin increased AGR2 mRNA **13‑fold** but did not increase AGR3 mRNA (bonser2015theendoplasmicreticulum pages 5-10).
- Ciliary beat frequency: **~20%** lower baseline CBF; **~35%** lower after ATP stimulation in Agr3−/− tracheas (bonser2015theendoplasmicreticulum pages 10-13).
- Mucociliary transport: **35%** reduction in particle transport speed in Agr3−/− tracheas (bonser2015theendoplasmicreticulum pages 10-13).
- Intracellular Ca2+: **139.7 ± 98.2 nM** (Agr3−/−) vs **362.1 ± 55.0 nM** (WT), n=6, p<0.001 (bonser2015theendoplasmicreticulum pages 10-13).

### 10) Structured summary of key evidence
| Topic | Key findings | Evidence type | Primary source (first author, journal) | Publication date (month year) | URL | Notes/limitations |
|---|---|---|---|---|---|---|
| Identity | Human AGR3 corresponds to UniProt Q8TD06 / PDIA18, an AGR-family, PDI-like protein encoded on chromosome 7p21.1; reported as a 166-aa protein of ~19.2 kDa (boisteau2022anteriorgradientproteins pages 6-10, bonser2015theendoplasmicreticulum pages 1-5) | Review synthesis of gene/protein annotation; primary experimental background | Boisteau, *Oncogene*; Bonser, *Am J Respir Cell Mol Biol* | Sep 2022; Oct 2015 | https://doi.org/10.1038/s41388-022-02452-1 ; https://doi.org/10.1165/rcmb.2014-0318oc | Annotation-level facts; not itself a direct functional assay |
| Domains / family | AGR3 is a small, single-domain PDI-family protein with a thioredoxin-like fold; it carries an N-terminal signal peptide for secretory-pathway entry and a noncanonical ER-retention motif QSEL (nguyen2018crystalstructureof pages 1-2, boisteau2022anteriorgradientproteins pages 6-10) | Crystal structure; review | Nguyen, *Acta Crystallogr F Struct Biol Commun*; Boisteau, *Oncogene* | Jun 2018; Sep 2022 | https://doi.org/10.1107/S2053230X18009093 ; https://doi.org/10.1038/s41388-022-02452-1 | Signal peptide/retention motif support localization but do not identify client proteins |
| Active-site motif / catalytic implication | AGR3 lacks the canonical PDI/thioredoxin CXXC or WCXXC motif; structure paper reports a DCYQS motif with solvent-exposed Cys71 in reduced state. Because the second catalytic cysteine is absent and an adjacent acidic residue likely raises cysteine pKa, AGR3 is inferred to have reduced/atypical thiol-disulfide exchange activity relative to classical PDIs (nguyen2018crystalstructureof pages 1-2, nguyen2018crystalstructureof pages 3-5, nguyen2018crystalstructureof pages 5-6, obaczUnknownyearinvestigationofagr3 pages 61-62) | Crystal structure; comparative structural inference | Nguyen, *Acta Crystallogr F Struct Biol Commun* | Jun 2018 | https://doi.org/10.1107/S2053230X18009093 | Catalytic activity is inferred structurally; no direct AGR3 enzymatic rate/substrate assay in provided snippets |
| Structural features / oligomerization | AGR3 adopts a thioredoxin fold with four β-strands and four α-helices, a bent helix 2, and cis-Pro117 near the DCYQS motif. Two molecules appear in the asymmetric unit, but biochemical/PISA analysis found no evidence for a stable dimer in solution; AGR3 lacks an AGR2-like inter-subunit salt-bridge component (nguyen2018crystalstructureof pages 3-5, nguyen2018crystalstructureof pages 5-6) | X-ray crystal structure | Nguyen, *Acta Crystallogr F Struct Biol Commun* | Jun 2018 | https://doi.org/10.1107/S2053230X18009093 | Structural study does not establish physiological oligomer state in cells |
| Subcellular localization | AGR3 is ER luminal/ER resident in ciliated airway cells. In human airway epithelium, 99.5% of AGR3 signal colocalized with ER markers GRP78/GRP94, and 97.7% of AGR3 staining was spatially distinct from AGR2. Review evidence also notes membrane and extracellular detection in some cancer contexts (bonser2015theendoplasmicreticulum pages 5-10, boisteau2022anteriorgradientproteins pages 6-10) | Immunostaining / colocalization; review synthesis | Bonser, *Am J Respir Cell Mol Biol*; Boisteau, *Oncogene* | Oct 2015; Sep 2022 | https://doi.org/10.1165/rcmb.2014-0318oc ; https://doi.org/10.1038/s41388-022-02452-1 | Membrane/extracellular localization in cancer is less mechanistically resolved than ER localization |
| Expression pattern | AGR3 is enriched in ciliated airway epithelial cells and increases strongly with epithelial differentiation; AGR3 mRNA rose by ~1000-fold from day 7 to day 21 in differentiated airway epithelial cultures. It is not induced by ER stress; tunicamycin increased AGR2 mRNA 13-fold but not AGR3 (bonser2015theendoplasmicreticulum pages 10-13, bonser2015theendoplasmicreticulum pages 5-10, bonser2015theendoplasmicreticulum pages 1-5, boisteau2022anteriorgradientproteins pages 1-6) | Differentiation time course; ER-stress perturbation | Bonser, *Am J Respir Cell Mol Biol*; Boisteau, *Oncogene* | Oct 2015; Sep 2022 | https://doi.org/10.1165/rcmb.2014-0318oc ; https://doi.org/10.1038/s41388-022-02452-1 | Expression data do not by themselves reveal molecular clients |
| Airway / ciliary function | Agr3-/- mice were viable and had morphologically normal cilia, but tracheal ciliary beat frequency (CBF) was reduced by ~20% at baseline; with ATP stimulation CBF was ~35% lower than controls. Mucociliary particle transport speed was reduced by 35%, supporting a role in mucociliary clearance rather than ciliogenesis (bonser2015theendoplasmicreticulum pages 10-13, bonser2015theendoplasmicreticulum pages 1-5) | Mouse knockout; ex vivo tracheal physiology | Bonser, *Am J Respir Cell Mol Biol* | Oct 2015 | https://doi.org/10.1165/rcmb.2014-0318oc | Evidence is strong for airway physiology, but does not identify direct AGR3 molecular substrate(s) |
| Calcium-linked mechanism | The CBF defect in Agr3-/- airways disappeared in calcium-free solution, and intracellular Ca2+ in cultured tracheal epithelial cells was lower in Agr3-/- vs wild type (139.7 ± 98.2 nM vs 362.1 ± 55.0 nM; n=6; p<0.001), implicating AGR3 in calcium-dependent regulation of ciliary activity (bonser2015theendoplasmicreticulum pages 10-13, bonser2015theendoplasmicreticulum pages 1-5) | Mouse knockout; calcium imaging | Bonser, *Am J Respir Cell Mol Biol* | Oct 2015 | https://doi.org/10.1165/rcmb.2014-0318oc | Mechanistic link to specific calcium-handling proteins remains unresolved in provided evidence |
| Cancer association (intracellular/expression) | AGR3 was first identified in breast tumor membranes; review evidence states expression correlates with estrogen receptor status, correlates with AGR2, and is reported to promote migration/metastasis. AGR3 has also been detected at the cell membrane and extracellularly in cancer contexts (boisteau2022anteriorgradientproteins pages 6-10) | Review synthesis drawing on earlier primary literature | Boisteau, *Oncogene* | Sep 2022 | https://doi.org/10.1038/s41388-022-02452-1 | Broad cancer statements are summarized from prior literature; quantitative tumor-outcome estimates are not given in the snippet |
| Extracellular AGR3 secretion | ER-positive breast cancer cell lines MCF-7 and T-47D secrete AGR3; conditioned media contained extracellular AGR3 at nanomolar concentrations. Serum eAGR3 was reported significantly elevated in breast cancer patients versus healthy controls (obacz2019extracellularagr3regulates pages 2-4, obacz2019extracellularagr3regulates pages 6-8) | Cell culture secretion assays; patient serum measurement | Obacz, *Oncology Letters* | Sep 2019 | https://doi.org/10.3892/ol.2019.10849 | Provided snippets do not include absolute serum concentrations or fold change |
| Extracellular AGR3 function in cancer | Recombinant eAGR3 promoted breast-cancer-cell migration and increased resistance to detachment/adhesion-related phenotypes. Functional assays used 5 ng/ml eAGR3 commonly, with testing across 0.5–50 ng/ml; migration was measured in wound-healing assays and adhesion in detachment assays (obacz2019extracellularagr3regulates pages 4-6, obacz2019extracellularagr3regulates pages 2-4, obacz2019extracellularagr3regulates pages 1-2) | Recombinant-protein treatment in breast cancer cell culture | Obacz, *Oncology Letters* | Sep 2019 | https://doi.org/10.3892/ol.2019.10849 | Exact effect sizes are not present in the provided snippets |
| Src signaling downstream of eAGR3 | eAGR3 increased tyrosine phosphorylation and c-Src phosphorylation. Dasatinib blocked c-Src phosphorylation and significantly reduced migration of control and eAGR3-stimulated cells; genetic interference with kinase-dead Src (K298R) abolished the migratory response to eAGR3. Dasatinib did not fully abolish migration, implying additional pathways may contribute (obacz2019extracellularagr3regulates pages 4-6, obacz2019extracellularagr3regulates pages 6-8, obacz2019extracellularagr3regulates pages 1-2) | Pharmacologic inhibition and dominant-negative Src in cell culture | Obacz, *Oncology Letters* | Sep 2019 | https://doi.org/10.3892/ol.2019.10849 | Strong evidence for Src involvement in vitro, but receptor(s) for eAGR3 and in vivo relevance remain unresolved |
| Known gaps | Across the provided evidence, no definitive AGR3-specific enzymatic substrate, direct folding client, or biochemical turnover measurement is established. Review and structure sources suggest possible roles in secretory/transmembrane protein biogenesis and possible mucin interaction by family analogy, but direct AGR3 client validation is lacking in the cited snippets (nguyen2018crystalstructureof pages 1-2, boisteau2022anteriorgradientproteins pages 1-6, boisteau2022anteriorgradientproteins pages 6-10) | Cross-source synthesis | Nguyen, *Acta Crystallogr F Struct Biol Commun*; Boisteau, *Oncogene* | Jun 2018; Sep 2022 | https://doi.org/10.1107/S2053230X18009093 ; https://doi.org/10.1038/s41388-022-02452-1 | Important limitation for functional annotation: much of AGR3 biochemistry remains inferential rather than directly measured |


*Table: This table summarizes the key experimentally supported properties and functions of human AGR3 (UniProt Q8TD06) from the provided evidence only. It highlights what is well supported—especially ER localization, ciliary function, and extracellular cancer signaling—and where important mechanistic gaps remain.*

### References (URLs and dates)
- Bonser LR et al. *American Journal of Respiratory Cell and Molecular Biology* (Oct 2015). “The Endoplasmic Reticulum Resident Protein AGR3. Required for Regulation of Ciliary Beat Frequency in the Airway.” https://doi.org/10.1165/rcmb.2014-0318oc (bonser2015theendoplasmicreticulum pages 10-13, bonser2015theendoplasmicreticulum pages 5-10, bonser2015theendoplasmicreticulum pages 1-5)
- Nguyen VD et al. *Acta Crystallographica Section F: Structural Biology Communications* (Jun 2018). “Crystal structure of human anterior gradient protein 3.” https://doi.org/10.1107/S2053230X18009093 (nguyen2018crystalstructureof pages 1-2, nguyen2018crystalstructureof pages 3-5, nguyen2018crystalstructureof pages 5-6)
- Obacz J et al. *Oncology Letters* (Sep 2019). “Extracellular AGR3 regulates breast cancer cells migration via Src signaling.” https://doi.org/10.3892/ol.2019.10849 (obacz2019extracellularagr3regulates pages 4-6, obacz2019extracellularagr3regulates pages 2-4, obacz2019extracellularagr3regulates pages 6-8)
- Boisteau E et al. *Oncogene* (Sep 2022). “Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology.” https://doi.org/10.1038/s41388-022-02452-1 (boisteau2022anteriorgradientproteins pages 6-10, boisteau2022anteriorgradientproteins pages 1-6)


References

1. (bonser2015theendoplasmicreticulum pages 1-5): Luke R. Bonser, Bradley W. Schroeder, Lisa A. Ostrin, Nathalie Baumlin, Jean L. Olson, Matthias Salathe, and David J. Erle. The endoplasmic reticulum resident protein agr3. required for regulation of ciliary beat frequency in the airway. American journal of respiratory cell and molecular biology, 53 4:536-43, Oct 2015. URL: https://doi.org/10.1165/rcmb.2014-0318oc, doi:10.1165/rcmb.2014-0318oc. This article has 32 citations and is from a peer-reviewed journal.

2. (boisteau2022anteriorgradientproteins pages 6-10): Emeric Boisteau, Céline Posseme, Federico Di Modugno, Julien Edeline, Cédric Coulouarn, Roman Hrstka, Andrea Martisova, Frédéric Delom, Xavier Treton, Leif A. Eriksson, Eric Chevet, Astrid Lièvre, and Eric Ogier-Denis. Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology. Oncogene, 41:4673-4685, Sep 2022. URL: https://doi.org/10.1038/s41388-022-02452-1, doi:10.1038/s41388-022-02452-1. This article has 15 citations and is from a domain leading peer-reviewed journal.

3. (nguyen2018crystalstructureof pages 1-2): Van Dat Nguyen, Ekaterina Biterova, Mikko Salin, Rik K. Wierenga, and Lloyd W. Ruddock. Crystal structure of human anterior gradient protein 3. Acta Crystallographica Section F Structural Biology Communications, 74:425-430, Jun 2018. URL: https://doi.org/10.1107/s2053230x18009093, doi:10.1107/s2053230x18009093. This article has 7 citations.

4. (boisteau2022anteriorgradientproteins pages 1-6): Emeric Boisteau, Céline Posseme, Federico Di Modugno, Julien Edeline, Cédric Coulouarn, Roman Hrstka, Andrea Martisova, Frédéric Delom, Xavier Treton, Leif A. Eriksson, Eric Chevet, Astrid Lièvre, and Eric Ogier-Denis. Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology. Oncogene, 41:4673-4685, Sep 2022. URL: https://doi.org/10.1038/s41388-022-02452-1, doi:10.1038/s41388-022-02452-1. This article has 15 citations and is from a domain leading peer-reviewed journal.

5. (nguyen2018crystalstructureof pages 5-6): Van Dat Nguyen, Ekaterina Biterova, Mikko Salin, Rik K. Wierenga, and Lloyd W. Ruddock. Crystal structure of human anterior gradient protein 3. Acta Crystallographica Section F Structural Biology Communications, 74:425-430, Jun 2018. URL: https://doi.org/10.1107/s2053230x18009093, doi:10.1107/s2053230x18009093. This article has 7 citations.

6. (nguyen2018crystalstructureof pages 3-5): Van Dat Nguyen, Ekaterina Biterova, Mikko Salin, Rik K. Wierenga, and Lloyd W. Ruddock. Crystal structure of human anterior gradient protein 3. Acta Crystallographica Section F Structural Biology Communications, 74:425-430, Jun 2018. URL: https://doi.org/10.1107/s2053230x18009093, doi:10.1107/s2053230x18009093. This article has 7 citations.

7. (bonser2015theendoplasmicreticulum pages 5-10): Luke R. Bonser, Bradley W. Schroeder, Lisa A. Ostrin, Nathalie Baumlin, Jean L. Olson, Matthias Salathe, and David J. Erle. The endoplasmic reticulum resident protein agr3. required for regulation of ciliary beat frequency in the airway. American journal of respiratory cell and molecular biology, 53 4:536-43, Oct 2015. URL: https://doi.org/10.1165/rcmb.2014-0318oc, doi:10.1165/rcmb.2014-0318oc. This article has 32 citations and is from a peer-reviewed journal.

8. (bonser2015theendoplasmicreticulum pages 10-13): Luke R. Bonser, Bradley W. Schroeder, Lisa A. Ostrin, Nathalie Baumlin, Jean L. Olson, Matthias Salathe, and David J. Erle. The endoplasmic reticulum resident protein agr3. required for regulation of ciliary beat frequency in the airway. American journal of respiratory cell and molecular biology, 53 4:536-43, Oct 2015. URL: https://doi.org/10.1165/rcmb.2014-0318oc, doi:10.1165/rcmb.2014-0318oc. This article has 32 citations and is from a peer-reviewed journal.

9. (obacz2019extracellularagr3regulates pages 2-4): Joanna Obacz, Lucia Sommerova, Daria Sicari, Michal Durech, Tony Avril, Filippo Iuliano, Silvia Pastorekova, Roman Hrstka, Eric Chevet, Frederic Delom, and Delphine Fessart. Extracellular agr3 regulates breast cancer cells migration via src signaling. Oncology Letters, 18:4449-4456, Sep 2019. URL: https://doi.org/10.3892/ol.2019.10849, doi:10.3892/ol.2019.10849. This article has 22 citations and is from a peer-reviewed journal.

10. (obacz2019extracellularagr3regulates pages 6-8): Joanna Obacz, Lucia Sommerova, Daria Sicari, Michal Durech, Tony Avril, Filippo Iuliano, Silvia Pastorekova, Roman Hrstka, Eric Chevet, Frederic Delom, and Delphine Fessart. Extracellular agr3 regulates breast cancer cells migration via src signaling. Oncology Letters, 18:4449-4456, Sep 2019. URL: https://doi.org/10.3892/ol.2019.10849, doi:10.3892/ol.2019.10849. This article has 22 citations and is from a peer-reviewed journal.

11. (obacz2019extracellularagr3regulates pages 4-6): Joanna Obacz, Lucia Sommerova, Daria Sicari, Michal Durech, Tony Avril, Filippo Iuliano, Silvia Pastorekova, Roman Hrstka, Eric Chevet, Frederic Delom, and Delphine Fessart. Extracellular agr3 regulates breast cancer cells migration via src signaling. Oncology Letters, 18:4449-4456, Sep 2019. URL: https://doi.org/10.3892/ol.2019.10849, doi:10.3892/ol.2019.10849. This article has 22 citations and is from a peer-reviewed journal.

12. (obaczUnknownyearinvestigationofagr3 pages 61-62): J Obacz. Investigation of agr3 protein function and mechanisms triggering its expression in cancer cell. Unknown journal, Unknown year.

13. (obacz2019extracellularagr3regulates pages 1-2): Joanna Obacz, Lucia Sommerova, Daria Sicari, Michal Durech, Tony Avril, Filippo Iuliano, Silvia Pastorekova, Roman Hrstka, Eric Chevet, Frederic Delom, and Delphine Fessart. Extracellular agr3 regulates breast cancer cells migration via src signaling. Oncology Letters, 18:4449-4456, Sep 2019. URL: https://doi.org/10.3892/ol.2019.10849, doi:10.3892/ol.2019.10849. This article has 22 citations and is from a peer-reviewed journal.

## Artifacts

- [Edison artifact artifact-00](AGR3-deep-research-falcon_artifacts/artifact-00.md)

## Citations

1. nguyen2018crystalstructureof pages 1-2
2. nguyen2018crystalstructureof pages 3-5
3. bonser2015theendoplasmicreticulum pages 5-10
4. bonser2015theendoplasmicreticulum pages 10-13
5. boisteau2022anteriorgradientproteins pages 6-10
6. bonser2015theendoplasmicreticulum pages 1-5
7. boisteau2022anteriorgradientproteins pages 1-6
8. nguyen2018crystalstructureof pages 5-6
9. https://doi.org/10.1038/s41388-022-02452-1
10. https://doi.org/10.1165/rcmb.2014-0318oc
11. https://doi.org/10.1107/S2053230X18009093
12. https://doi.org/10.3892/ol.2019.10849
13. https://doi.org/10.1165/rcmb.2014-0318oc,
14. https://doi.org/10.1038/s41388-022-02452-1,
15. https://doi.org/10.1107/s2053230x18009093,
16. https://doi.org/10.3892/ol.2019.10849,